Protective actions of bioactive flavonoids chrysin and luteolin on the glyoxal induced formation of advanced glycation end products and aggregation of human serum albumin: In vitro and molecular docking analysis.

[1]  Atanu Singha Roy,et al.  Elucidation of molecular interaction of bioactive flavonoid luteolin with human serum albumin and its glycated analogue using multi-spectroscopic and computational studies , 2020 .

[2]  Guowen Zhang,et al.  Molecular characteristics of gallocatechin gallate affecting protein glycation , 2020 .

[3]  Sauradipta Banerjee.  Glyoxal modification mediates conformational alterations in silk fibroin: Induction of fibrillation with amyloidal features , 2020, Journal of Biosciences.

[4]  Sourav Das,et al.  Non-enzymatic glycation of human serum albumin modulates its binding efficacy towards bioactive flavonoid chrysin: A detailed study using multi-spectroscopic and computational methods , 2020, Journal of biomolecular structure & dynamics.

[5]  Amitabha Acharya,et al.  Inhibition of Glycation-Induced Aggregation of Human Serum Albumin by Organic–Inorganic Hybrid Nanocomposites of Iron Oxide-Functionalized Nanocellulose , 2019, ACS omega.

[6]  Y. Chen,et al.  Protein Glycation by Glyoxal Promotes Amyloid Formation by Islet Amyloid Polypeptide. , 2019, Biophysical journal.

[7]  Sourav Das,et al.  Lysozyme-luteolin binding: molecular insights into the complexation process and the inhibitory effects of luteolin towards protein modification. , 2019, Physical chemistry chemical physics : PCCP.

[8]  G. Rabbani,et al.  Structure, enzymatic activities, glycation and therapeutic potential of human serum albumin: A natural cargo. , 2019, International journal of biological macromolecules.

[9]  I. Naseem,et al.  Study of pyridoxamine against glycation and reactive oxygen species production in human serum albumin as model protein: An in vitro & ex vivo approach. , 2018, International journal of biological macromolecules.

[10]  P. Jing,et al.  Spectroscopic and molecular modelling studies on glycation modified bovine serum albumin with cyanidin-3-O-glucoside. , 2018, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[11]  C. Luna,et al.  Antioxidant and pro-oxidant actions of resveratrol on human serum albumin in the presence of toxic diabetes metabolites: Glyoxal and methyl-glyoxal. , 2018, Biochimica et biophysica acta. General subjects.

[12]  S. Bhayye,et al.  Andrographolide inhibits human serum albumin fibril formations through site-specific molecular interactions , 2018, RSC advances.

[13]  I. Choi,et al.  Roles of osmolytes in protein folding and aggregation in cells and their biotechnological applications. , 2018, International journal of biological macromolecules.

[14]  F. Husain,et al.  Methylglyoxal induced glycation and aggregation of human serum albumin: Biochemical and biophysical approach. , 2018, International journal of biological macromolecules.

[15]  K. Ahmad,et al.  Binding of Tolperisone Hydrochloride with Human Serum Albumin: Effects on the Conformation, Thermodynamics, and Activity of HSA. , 2018, Molecular pharmaceutics.

[16]  K. Alam,et al.  Fructose-human serum albumin interaction undergoes numerous biophysical and biochemical changes before forming AGEs and aggregates. , 2017, International journal of biological macromolecules.

[17]  Asad U. Khan,et al.  New insights into non-enzymatic glycation of human serum albumin biopolymer: A study to unveil its impaired structure and function. , 2017, International journal of biological macromolecules.

[18]  Won-Kyung Cho,et al.  Biophysical Study on the Interaction between Eperisone Hydrochloride and Human Serum Albumin Using Spectroscopic, Calorimetric, and Molecular Docking Analyses. , 2017, Molecular pharmaceutics.

[19]  R. H. Khan,et al.  Binding of erucic acid with human serum albumin using a spectroscopic and molecular docking study. , 2017, International journal of biological macromolecules.

[20]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[21]  N. Saraswathi,et al.  Linolenic acid prevents early and advanced glycation end-products (AGEs) modification of albumin. , 2017, International journal of biological macromolecules.

[22]  G. Rabbani,et al.  A spectroscopic and molecular docking approach on the binding of tinzaparin sodium with human serum albumin , 2017 .

[23]  G. Rabbani,et al.  Calorimetric and spectroscopic binding studies of amoxicillin with human serum albumin , 2017, Journal of Thermal Analysis and Calorimetry.

[24]  A. Chakraborti,et al.  Glyoxal administration induces formation of high molecular weight aggregates of hemoglobin exhibiting amyloidal nature in experimental rats: An in vivo study. , 2016, International journal of biological macromolecules.

[25]  D. Gong,et al.  Inhibitory mechanism of morin on α-glucosidase and its anti-glycation properties. , 2016, Food & function.

[26]  S. Dasgupta,et al.  Glycation of human serum albumin alters its binding efficacy towards the dietary polyphenols: a comparative approach , 2016, Journal of biomolecular structure & dynamics.

[27]  Vincent Zoete,et al.  A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules , 2016, ChemMedChem.

[28]  F. Shahidi,et al.  Antiglycation activity of lipophilized epigallocatechin gallate (EGCG) derivatives. , 2016, Food chemistry.

[29]  I. Naseem,et al.  Inhibitory effect of quercetin in the formation of advance glycation end products of human serum albumin: An in vitro and molecular interaction study. , 2015, International journal of biological macromolecules.

[30]  Gulam Rabbani,et al.  Non-fluorinated cosolvents: A potent amorphous aggregate inducer of metalloproteinase-conalbumin (ovotransferrin). , 2015, International journal of biological macromolecules.

[31]  R. H. Khan,et al.  Glycation of H1 Histone by 3-Deoxyglucosone: Effects on Protein Structure and Generation of Different Advanced Glycation End Products , 2015, PloS one.

[32]  R. Bhat,et al.  Impact of structural stability of cold adapted Candida antarctica lipase B (CaLB): in relation to pH, chemical and thermal denaturation , 2015 .

[33]  R. H. Khan,et al.  3-Deoxyglucosone: A Potential Glycating Agent Accountable for Structural Alteration in H3 Histone Protein through Generation of Different AGEs , 2015, PloS one.

[34]  R. H. Khan,et al.  Biophysical investigation of thymoquinone binding to ‘N’ and ‘B’ isoforms of human serum albumin: exploring the interaction mechanism and radical scavenging activity , 2015 .

[35]  A. Moosavi-Movahedi,et al.  Natural peptide anti-glycation effect in the presence of Aloe vera phenolic components on human serum albumin , 2015 .

[36]  S. Sang,et al.  Quercetin inhibits advanced glycation end product formation by trapping methylglyoxal and glyoxal. , 2014, Journal of agricultural and food chemistry.

[37]  A. Saboury,et al.  Honey bee venom decreases the complications of diabetes by preventing hemoglobin glycation , 2014 .

[38]  R. H. Khan,et al.  Effect of copper oxide nanoparticles on the conformation and activity of β-galactosidase. , 2014, Colloids and surfaces. B, Biointerfaces.

[39]  R. H. Khan,et al.  Physicochemical analysis of structural alteration and advanced glycation end products generation during glycation of H2A histone by 3‐deoxyglucosone , 2014, IUBMB life.

[40]  Ejaz Ahmad,et al.  Fluoroalcohols-induced modulation and amyloid formation in conalbumin. , 2014, International journal of biological macromolecules.

[41]  Asif Ali,et al.  Methylglyoxal mediated conformational changes in histone H2A-generation of carboxyethylated advanced glycation end products. , 2014, International journal of biological macromolecules.

[42]  A. Chakraborti,et al.  Structural alterations of hemoglobin and myoglobin by glyoxal: a comparative study. , 2014, International journal of biological macromolecules.

[43]  I. Sadowska-Bartosz,et al.  Kinetics of Glycoxidation of Bovine Serum Albumin by Methylglyoxal and Glyoxal and its Prevention by Various Compounds , 2014, Molecules.

[44]  R. H. Khan,et al.  Cosolvents Induced Unfolding and Aggregation of Keyhole Limpet Hemocyanin , 2013, Cell Biochemistry and Biophysics.

[45]  R. H. Khan,et al.  Molten Globule of Hemoglobin Proceeds into Aggregates and Advanced Glycated End Products , 2013, PloS one.

[46]  S. Jain,et al.  BIOTECHNOLOGICALLY RELEVANT ENZYMES AND PROTEINS Structural characteristics of thermostable immunogenic outer membrane protein from Salmonella enterica serovar Typhi , 2014 .

[47]  M. Ubukata,et al.  Protective effects of hesperidin derivatives and their stereoisomers against advanced glycation end-products formation , 2012, Pharmaceutical biology.

[48]  M. Mamas,et al.  Role of advanced glycation end products in cardiovascular disease. , 2012, World journal of cardiology.

[49]  E. Bourdon,et al.  Structural modifications of human albumin in diabetes. , 2012, Diabetes & metabolism.

[50]  Ejaz Ahmad,et al.  pH-Induced Molten Globule State of Rhizopus niveus Lipase is More Resistant Against Thermal and Chemical Denaturation Than Its Native State , 2012, Cell Biochemistry and Biophysics.

[51]  R. Bhat,et al.  Stereo-Selectivity of Human Serum Albumin to Enantiomeric and Isoelectronic Pollutants Dissected by Spectroscopy, Calorimetry and Bioinformatics , 2011, PloS one.

[52]  Ejaz Ahmad,et al.  pH-Dependent Conformational Transitions in Conalbumin (Ovotransferrin), a Metalloproteinase from Hen Egg White , 2011, Cell Biochemistry and Biophysics.

[53]  E. Bourdon,et al.  The glycation of albumin: structural and functional impacts. , 2011, Biochimie.

[54]  P. Balaram,et al.  Apoptotic Effects of Chrysin in Human Cancer Cell Lines , 2010, International journal of molecular sciences.

[55]  R. H. Khan,et al.  Acid-induced unfolding of didecameric keyhole limpet hemocyanin: detection and characterizations of decameric and tetrameric intermediate states , 2010, Amino Acids.

[56]  W. R. Bruce,et al.  Fructose and carbonyl metabolites as endogenous toxins. , 2009, Chemico-biological interactions.

[57]  Kwan Y Choi,et al.  The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process. , 2009, Biochimica et biophysica acta.

[58]  Yong Lin,et al.  Luteolin, a flavonoid with potential for cancer prevention and therapy. , 2008, Current cancer drug targets.

[59]  N. Sheibani,et al.  Detergency effects of nanofibrillar amyloid formation on glycation of human serum albumin. , 2008, Carbohydrate research.

[60]  M. Peppa,et al.  Advanced glycation end products and cardiovascular disease. , 2008, Current diabetes reviews.

[61]  B. Rosner,et al.  A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer , 2007, International journal of cancer.

[62]  F. Ahmad,et al.  Formation of the molten globule-like state during prolonged glycation of human serum albumin. , 2007, Biochimica et biophysica acta.

[63]  W. Prinyawiwatkul,et al.  Antioxidant activities of different colored sweet bell peppers (Capsicum annuum L.). , 2007, Journal of food science.

[64]  A. Tyner,et al.  Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[65]  S. Curry,et al.  Structural basis of the drug-binding specificity of human serum albumin. , 2005, Journal of molecular biology.

[66]  Paul J Thornalley,et al.  Peptide Mapping of Human Serum Albumin Modified Minimally by Methylglyoxal in Vitro and in Vivo , 2005, Annals of the New York Academy of Sciences.

[67]  G. Yen,et al.  Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. , 2005, Journal of agricultural and food chemistry.

[68]  J. Schmitt,et al.  Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics. , 2005, Analytical biochemistry.

[69]  I. Mikšík,et al.  Non-enzymatic posttranslational modifications of bovine serum albumin by oxo-compounds investigated by chromatographic and electrophoretic methods. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[70]  A. Donald,et al.  The binding of thioflavin-T to amyloid fibrils: localisation and implications. , 2005, Journal of structural biology.

[71]  M. Neuhouser.  Review: Dietary Flavonoids and Cancer Risk: Evidence From Human Population Studies , 2004, Nutrition and cancer.

[72]  P. Kumar,et al.  Effect of dicarbonyl-induced browning on alpha-crystallin chaperone-like activity: physiological significance and caveats of in vitro aggregation assays. , 2004, The Biochemical journal.

[73]  P. D. de Groot,et al.  Glycation Induces Formation of Amyloid Cross-β Structure in Albumin* , 2003, Journal of Biological Chemistry.

[74]  Toru Maruyama,et al.  The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. , 2003, Biochimica et biophysica acta.

[75]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[76]  Alice Maroudas,et al.  Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. , 2002, Arthritis and rheumatism.

[77]  A. Poljak,et al.  Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin. , 2001, Biochemical and biophysical research communications.

[78]  W. Oleszek,et al.  Antioxidant and antiradical activities of flavonoids. , 2001, Journal of agricultural and food chemistry.

[79]  C. Rice-Evans,et al.  Flavonoid B-ring chemistry and antioxidant activity: fast reaction kinetics. , 2001, Biochemical and biophysical research communications.

[80]  P. Riederer,et al.  Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation? , 2000, Journal of Chemical Neuroanatomy.

[81]  J. Harborne,et al.  Advances in flavonoid research since 1992. , 2000, Phytochemistry.

[82]  R. Nagaraj,et al.  Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes. , 1999, Archives of biochemistry and biophysics.

[83]  C van Ypersele de Strihou,et al.  Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. , 1999, Kidney international.

[84]  M F Sanner,et al.  Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.

[85]  I. Mikšík,et al.  Post-translational non-enzymatic modification of proteins. II. Separation of selected protein species after glycation and other carbonyl-mediated modifications. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[86]  H. Vlassara.  Advanced glycosylation in nephropathy of diabetes and aging. , 1996, Advances in nephrology from the Necker Hospital.

[87]  D S Goodsell,et al.  Automated docking of flexible ligands: Applications of autodock , 1996, Journal of molecular recognition : JMR.

[88]  Paul J Thornalley,et al.  Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins , 1995, Journal of protein chemistry.

[89]  T. Peters.  Genetics: The Albumin Gene , 1995 .

[90]  R. Bucala,et al.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[91]  M. Cohen,et al.  Purification of glycated hemoglobin. , 1994, Methods in enzymology.

[92]  T. Lyons,et al.  Accumulation of Maillard reaction products in skin collagen in diabetes and aging. , 1993, The Journal of clinical investigation.

[93]  D. Carter,et al.  Atomic structure and chemistry of human serum albumin , 1992, Nature.

[94]  M. Hosokawa,et al.  Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.

[95]  U Kragh-Hansen,et al.  Molecular aspects of ligand binding to serum albumin. , 1981, Pharmacological reviews.

[96]  J. Baynes,et al.  Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[97]  G. Sudlow,et al.  The characterization of two specific drug binding sites on human serum albumin. , 1975, Molecular pharmacology.